← Browse by Condition
Medical Condition

proc

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT07470853 Phase 1
Recruiting

A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.

Enrollment
265 pts
Location
United States
Sponsor
Whitehawk Therapeutics, Inc.
View Trial →